An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases

David E. Griffith, Timothy Aksamit, Barbara A. Brown-Elliott, Antonino Catanzaro, Charles Daley, Fred Gordin, Steven M. Holland, Robert Horsburgh, Gwen Huitt, Michael F. Iademarco, Michael Iseman, Kenneth Olivier, Stephen Ruoss, C. Fordham Von Reyn, Richard J. Wallace, Kevin Winthrop

Research output: Contribution to journalReview articlepeer-review

4725 Scopus citations

Abstract

The minimum evaluation of a patient suspected of nontuberculous mycobacterial (NTM) lung disease should include the following: (1) chest radiograph or, in the absence of cavitation, chest high-resolution computed tomography (HRCT) scan; (2) three ormore sputumspecimens for acid-fast bacilli (AFB) analysis; and (3) exclusion of other disorders, such as tuberculosis (TB). Clinical, radiographic, and microbiologic criteria are equally important and all must be met to make a diagnosis of NTM lung disease. The following criteria apply to symptomatic patients with radiographic opacities, nodular or cavitary, or an HRCT scan that shows multifocal bronchiectasis with multiple small nodules. These criteria fit best with Mycobacterium avium complex (MAC), M. kansasii, and M. abscessus. There is not enough known about most other NTM to be certain that these diagnostic criteria are universally applicable for all NTM respiratory pathogens.

Original languageEnglish (US)
Pages (from-to)367-416
Number of pages50
JournalAmerican journal of respiratory and critical care medicine
Volume175
Issue number4
DOIs
StatePublished - Feb 15 2007

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Fingerprint

Dive into the research topics of 'An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases'. Together they form a unique fingerprint.

Cite this